Press Release: EmerRx Biopharma Announces Reg. CF Private Placement Offering
Alameda, CA – September 26, 2025 – EmerRx Biopharma is pleased to announce the launch of a private placement offering in accordance with Regulation Crowdfunding (Reg. CF) adopted by the U.S. Securities and Exchange Commission (SEC) through MicroVentures.
More information on this offering can be found at: https://invest.microventures.com/offerings/emerrx.
“We’re incredibly excited about this new chapter,” said Dr. Mitch Raponi, CEO of EmerRx Biopharma. “Partnering with MicroVentures allows us to broaden our investor base and engage with a community of supporters who believe in our mission of advancing innovative drug delivery solutions.”
About EmerRx Biopharma
EmerRx Biopharma is a pioneering biopharmaceutical company focused on next-generation drug delivery innovations, including intranasal formulations of critical therapeutics. With a commitment to improving patient outcomes, EmerRx leverages cutting-edge technology and collaborative partnerships to deliver innovative healthcare solutions.
About MicroVentures
About MicroVenture Marketplace, Inc.: MicroVenture Marketplace (“MicroVentures) is a registered broker/dealer and member of FINRA and SIPC. MicroVentures offers the sale of private placements in early and late-stage companies in various industries, facilitates secondary transactions in private companies, serves as a placement agent for Regulation A+ offerings, and serves as a crowdfunding intermediary in accordance with Regulation CF. Please visit https://microventures.com for more information.
A crowdfunding investment involves risk, including illiquidity, potential loss of principal, and dilution. In making an investment decision, investors must rely on their own examination of the issuer and the terms of the offering. The securities offered have not been recommended or approved by any federal or state securities commission or regulatory authority.
Inquiries related to EmerRx Biopharma:
Mitch Raponi
mitch@emerrx.com
emerrx.com
Questions regarding the Crowd Note offering:
https://invest.microventures.com/offerings/emerrx/